InvestorsHub Logo
Followers 32
Posts 3544
Boards Moderated 0
Alias Born 07/02/2004

Re: duelittle2 post# 3294

Saturday, 01/30/2010 6:55:00 PM

Saturday, January 30, 2010 6:55:00 PM

Post# of 18334
This test is old news. It's the urine test that will make HDVY a household name.

Clarient Launches Gene Expression Test for Prostate Cancer

1/13/2009

Source: BUSINESS WIRE

Gene Profile Discovered By Health Discovery Corporation Will Provide Molecular Confirmation of Gleason Grade 3 and 4 Cancer Cells in Prostate Biopsies

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the commercial launch of its new gene expression test for prostate cancer. This new test will be available through Clarient’s PATHSiTETM virtual reporting tool and accessible to the company’s entire pathology network

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News